Karyopharm Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $108.4M
Liabilities Breakdown FY2025
Total Liabilities: $401.3M
Asset Breakdown
Total Assets: $108.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $60.5M | 55.8% |
| Accounts Receivable | $26.2M | 24.1% |
| Inventory | $4.0M | 3.7% |
| Property, Plant & Equipment | $104.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $17.6M | 16.2% |
Liabilities Breakdown
Total Liabilities: $401.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.0M | 1.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $397.3M | 99.0% |